Helius Medical Technologies, Inc. provided revenue guidance for the first quarter of 2022. For the period, the company expects revenue to range from $150,000 to $170,000 and quarterly revenue to increase sequentially each quarter throughout the year as the U.S. commercialization of PoNS develops.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | -3.12% | -16.22% | -84.58% |
13/05 | Transcript : Helius Medical Technologies, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
13/05 | Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.58% | 4.64M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2022